|
Medical Device Recalls
Class 2 Recall
Guidant VITALITY AVT
|
|
Date Recall Initiated |
May 15, 2006
|
Date Posted |
July 27, 2006
|
Recall Number |
Z-1291-06
|
Product |
VITALITY AVT, model A155. Implantable Cardioverter Defibrillator. Atrial and Ventricular Therapies. Guidant Corporation Cardiac Rhythm Management, 4100 Hamline Avenue North, St. Paul, MN 55112-5798, USA.
|
Code Information |
model A155, serial numbers: 113567, 113568, 113569, 113570, 113572, 113574, 113585, 113586, 113587, 113591,
113612, 113613, 113616, 113617, 113618, 113619, 113620,
113621, 113623, 113624, 113626, 113627, 113628, 113629,
113631, 113633, 113635, 113637, 113639, 113640, 113641,
113654, 113659, 113660, 113672, 113674, 113675, 113676,
113678, 113679, 113680, 113681, 113682, 113684, 113686,
113687, 113690, 113693, 113694, 113695, 113696, 113778,
113779, 113781, 113783, 113784, 113789, 113791, 113792,
113814, 113908, 113910, 113912, 113913, 113914, 114083
|
Recalling Firm/ Manufacturer |
Boston Scientific CRM Corp
4100 Hamline Ave N
Saint Paul
, Minnesota
55112-5700
|
For Addition Information Contact |
Guidant
866-484-3268
|
Reason For Recall |
Guidant has identified a pattern of premature battery depletion in devices manufactured with a single lot of capacitors from a single supplier. If function of this low voltage capacitor is compromised, the battery may deplete prematurely.
|
Action |
An Urgent Medical Device Safety Information & Corrective Action letter, dated May 12, 2006, was sent to physicians. The letter gave a description of the issue, clinical implications, rate of occurrence, devices affected and recommendation. Physicians are asked to follow-up with affected patients as soon as possible because ERI to EOL time may be shortened. Physicians are asked to contact Guidant for instructions on performing a baseline 'save to disk' and provide this information to Guidant. Guidant will be able to analyze the device memory data and estimate remaining longevity and provide individualized follow-up and replacement guidelines. Subsequent follow-up visits should continue to monitor for evidence of premature battery depletion.
|
Quantity in Commerce |
66
|
Distribution |
Nationwide including Puerto Rico. Worldwide, including Argentina, Belgium, Canada, Denmark, France, Germany, Greece, Ireland, Italy, Netherlands, New Zealand, Portugal, Spain, Syrian Arab Republic, United Arab Emirates
|
|
|
|
|
|